Spa-1, a negative regulator of Rap1, is expressed following T cell receptor ligation and CD28 costimulation, and is expressed in a subset of rheumatoid arthritis synovial T cells.

被引：0
|
作者：
da Cruz, Tania C. [1 ]
Ariotti, Silvia [1 ]
Abreu, Joana R. [1 ]
Tak, Paul P. [1 ]
Reedquist, Kris A. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S751 / S751
页数：1
相关论文
共 47 条
  • [41] HUMAN T CELL LEUKEMIA VIRUS TYPE 1 (HTLV-1) EXACERBATES RHEUMATOID ARTHRITIS; EXOSOMES AND IFN-GAMMA DERIVED FROM HTLV-1 INFECTED CELLS ENHANCE THE INFLAMMATORY RESPONSE OF RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS VIA PATTERN RECOGNITION RECEPTOR, RIG-I
    Umekita, K.
    Miyauchi, S.
    Kubo, K.
    Kawano, A.
    Iwao, K.
    Komura, M.
    Matsuda, M.
    Takajo, I.
    Nomura, H.
    Nagatomo, Y.
    Okayama, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1054 - 1054
  • [42] Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma
    Strome, SE
    Martin, B
    Flies, D
    Tamada, K
    Chapoval, AI
    Sargent, DJ
    Shu, SY
    Chen, LP
    JOURNAL OF IMMUNOTHERAPY, 2000, 23 (04): : 430 - 437
  • [43] Prospect of combining telomerase-specific vaccination and adoptive T cell therapy by using artificial APC expressing anti-CD3/CD28 and 4-1BB-ligand to expand vaccine-generated specific cells.
    Maus, MV
    Chen, DY
    Vanderheide, RH
    BLOOD, 2002, 100 (11) : 672A - 672A
  • [44] THE MAJORITY OF THE SYNOVIAL-FLUID DELTA-TSC1+ CELLS IN JUVENILE RHEUMATOID-ARTHRITIS CARRY THE VIRGIN T-CELL PHENOTYPE BUT EXPRESS THE EARLY ACTIVATION MARKER CD69 - SHORT-TERM CULTURE OF T-GAMMA-DELTA-CELLS IN IL2 INDUCE THE EXPRESSION OF CD69
    KJELDSENKRAGH, J
    QUAYLE, AJ
    VINLE, O
    NATVIG, JB
    FORRE, O
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (04) : 633 - 633
  • [45] CD22-Targeted Chimeric Antigen Receptor (CAR) T Cells Containing The 4-1BB Costimulatory Domain Demonstrate Enhanced Persistence and Superior Efficacy Against B-Cell Precursor Acute Lymphoblastic Leukemia (ALL) Compared To Those Containing CD28
    Haso, Waleed
    Qin, Haiying
    Zhang, Ling
    Orentas, Rimas J.
    Fry, Terry J.
    BLOOD, 2013, 122 (21)
  • [46] A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T- Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE)
    Weinkove, Robert
    George, Philip
    Fyfe, Robert
    Dasyam, Nathaniel
    Nouri, Yasmin
    Ostapowicz, Tess
    Mullins, Stefan
    Mester, Brigitta
    Giunti, Giulia
    Bollard, Catherine M.
    Perera, Travis
    Jina, Hayden
    D'Souza, Alwyn
    Qin, Le
    Ritchie, David S.
    Frampton, Chris M. A.
    Perret, Rachel
    Li, Peng
    Hermans, Ian
    BLOOD, 2023, 142
  • [47] The mouse CD94/NKG2A natural killer cell receptor for the non-classical MHC class I molecule Qa-1b is constitutively expressed on ICD8+ T cells and inhibits TCR-mediated cytolysis.
    Lohwasser, S
    Kubota, A
    Salcedo, M
    Lian, R
    Takei, F
    BLOOD, 1999, 94 (10) : 7A - 7A
12345